Correlation Between Visa and Ibnsina Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Ibnsina Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Ibnsina Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Ibnsina Pharma, you can compare the effects of market volatilities on Visa and Ibnsina Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Ibnsina Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Ibnsina Pharma.

Diversification Opportunities for Visa and Ibnsina Pharma

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Visa and Ibnsina is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Ibnsina Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibnsina Pharma and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Ibnsina Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibnsina Pharma has no effect on the direction of Visa i.e., Visa and Ibnsina Pharma go up and down completely randomly.

Pair Corralation between Visa and Ibnsina Pharma

Taking into account the 90-day investment horizon Visa is expected to generate 11.68 times less return on investment than Ibnsina Pharma. But when comparing it to its historical volatility, Visa Class A is 4.93 times less risky than Ibnsina Pharma. It trades about 0.13 of its potential returns per unit of risk. Ibnsina Pharma is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  551.00  in Ibnsina Pharma on September 20, 2024 and sell it today you would earn a total of  121.00  from holding Ibnsina Pharma or generate 21.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy85.71%
ValuesDaily Returns

Visa Class A  vs.  Ibnsina Pharma

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Ibnsina Pharma 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ibnsina Pharma are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Ibnsina Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Visa and Ibnsina Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Ibnsina Pharma

The main advantage of trading using opposite Visa and Ibnsina Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Ibnsina Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibnsina Pharma will offset losses from the drop in Ibnsina Pharma's long position.
The idea behind Visa Class A and Ibnsina Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity